CDC vaccine advisers put off decision on Johnson & Johnson Covid-19 vaccine

Vaccine advisers to the US Centers for Disease Control and Prevention on Wednesday put off making any decision about the recommendations for Johnson & Johnson's coronavirus vaccine. Vaccine advisers to the US Centers for Disease Control and Prevention on Wednesday put off making any decision about the recommendations for Johnson & Johnson's coronavirus vaccine, saying they need more information about a rare type of blood clot.

ACIP staff said they would quickly look for a time that the committee could meet again so the vaccine is not unnecessarily delayed if they decide it's safe to continue giving it. He gave details of what's known about the cases, which include: a 45-year-old woman who died; a 38-year-old woman who has not recovered; an 18-year-old woman who has not recovered; a 48-year-old woman who has not recovered; a 26-year-old woman who has recovered and a 28-year-old woman whose status is unknown.

"I just don't feel there's enough information to make an evidence-based decision. We won't have all the information, but I think there are some things that we can gather relatively quickly, which all have to do with the benefit/risk balance," Bell said. Both vaccines use adenoviruses, a type of common cold virus, to carry genetic material from the coronavirus into the body to elicit immunity. One theory is that these adenoviruses somehow prompt an immune response that causes the low platelet count and the blood clots.

"We are in a situation where not making a decision is tantamount to making a decision," Shah said, noting that people who could benefit from getting a one-dose vaccine would go unvaccinated as a result of further delay.

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tsansang makuha ang COVID-19 sa mga surface mababa, ayon sa CDC; DOH may paalalaTsansang makuha ang COVID19 sa mga surface mababa, ayon sa CDC; DOH may paalala
Source: ABSCBNNews - 🏆 5. / 83 Read more »

U.S. CDC expands COVID-19 vaccine eligibility to 16 and olderEveryone in United States aged 16 years and above is now eligible for COVID-19 vaccination, the U.S. Centers for Disease Control and Prevention (CDC) said on Monday. Bryan Wood reports.
Source: inquirerdotnet - 🏆 3. / 86 Read more »

U.S. administers 252 million doses of COVID-19 vaccines - CDCFigures are up from the 249,566,820 vaccine doses the CDC said had gone into arms by Wednesday out of 321,549,335 doses delivered.
Source: inquirerdotnet - 🏆 3. / 86 Read more »

CDC advisers vote to recommend use of Pfizer's COVID-19 vaccine in 12-15-year-oldsBREAKING via CNN: The CDC's Advisory Committee on Immunization Practices agreed the benefits of vaccinating children and teens outweigh any risks from the vaccine.
Source: CNN Philippines - 🏆 13. / 63 Read more »

CDC panel clears way to COVID-19 vaccines for US adolescentsUS states are now set to begin using the vaccine from Pfizer Inc and BioNTech SE to inoculate younger adolescents against COVID-19.
Source: ANCALERTS - 🏆 26. / 50 Read more »